Screener
Pacira BioSciences, Inc. PCRX Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Revenues: | ||
| Net product sales | $177,376 | $167,594 |
| Royalty revenue | — | 1,329 |
| Total revenues | 177,376 | 168,923 |
| Operating expenses: | ||
| Cost of goods sold (exclusive of amortization of acquired intangible assets) | 36,413 | 34,306 |
| Research and development | 28,072 | 25,342 |
| Selling, general and administrative | 93,944 | 86,776 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s total revenue?
- Pacira BioSciences, Inc. (PCRX) reported total revenue of $177.38M in Q1 2026.
- How has Pacira BioSciences, Inc.'s total revenue changed year-over-year?
- Pacira BioSciences, Inc.'s total revenue increased by 5.0% year-over-year, from $168.92M to $177.38M.
- What is the long-term trend for Pacira BioSciences, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s total revenue has grown at a 7.6% compound annual growth rate (CAGR), from $541.53M to $726.41M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Pacira BioSciences, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude